Sickle cell disease in childhood: Part I. Laboratory diagnosis, pathophysiology and health maintenance

D L Wethers1

  • 1St Luke's--Roosevelt Hospital Center, New York, New York, USA.

American Family Physician
|September 21, 2000
PubMed

Insights

Advances in newborn screening and early interventions have significantly reduced complications and mortality in children with sickle cell disease. Prophylactic penicillin and vaccinations have decreased sepsis incidence, improving overall health outcomes.

Area of Science:

  • Pediatrics
  • Hematology
  • Public Health

Background:

  • Sickle cell disease (SCD) historically led to high childhood morbidity and mortality.
  • New diagnostic tools and preventative strategies have emerged over the last 25 years.

Purpose of the Study:

  • To review the impact of modern medical advancements on pediatric sickle cell disease management.
  • To highlight key interventions that have improved outcomes for children with SCD.

Main Methods:

  • Review of medical literature and clinical guidelines over the past 25 years.
  • Analysis of trends in morbidity, mortality, and incidence of infectious complications in pediatric SCD.
  • Evaluation of the effectiveness of prophylactic penicillin, vaccinations, nutritional support, and screening protocols.

Main Results:

  • Significant decreases in morbidity and mortality for children with sickle cell disease.
  • Reduced incidence of sepsis due to *Streptococcus pneumoniae* and *Haemophilus influenzae* infections.
  • Improved growth and identification of complications like retinopathy and renal disease through screening and optimal nutrition.

Conclusions:

  • Newborn screening and early interventions are crucial for diagnosing and managing sickle cell disease.
  • Prophylactic penicillin and vaccinations have dramatically reduced infectious complications.
  • Educated healthcare providers and parents enable early detection and treatment of life-threatening SCD complications, improving long-term outcomes.

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Sputum Studies I: Gram Stain, cytology, and Acid-fast smear and culture01:26

Sputum Studies I: Gram Stain, cytology, and Acid-fast smear and culture

Sputum studies are a critical part of diagnosing and treating numerous respiratory conditions. These studies involve obtaining sputum samples for analysis to identify pathogenic organisms and assess the presence of abnormal cells indicative of malignant conditions. This lesson will delve into three fundamental sputum studies: Gram Stain, Cytology, and Acid-fast Smear and Culture.
Gram Stain
The Gram Stain is an integral part of sputum studies. It involves the staining of sputum, which permits...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...